Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Colleague Insights
Grand Rounds
Conferences
Video Expert Opinion
Living Resources
Sign in
Join now
featured
Published in Obesity, Metabolic Syndrome, and Prediabetes and
1 other channel

Expert Opinion / Interview · July 02, 2018

ADA 2018: SGLT2 Inhibitors in the Management of Type 2 Diabetes

Interview by
Jason Sloane MD
Interview with
John (Jack) L. Leahy MD

 

 Save  Recommend
 Share

Further Reading

Related Videos